.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Express Scripts
Covington
Merck
Deloitte
Colorcon
McKesson
Cantor Fitzgerald
Medtronic
US Army

Generated: November 19, 2017

DrugPatentWatch Database Preview

Claims for Patent: 7,662,365

« Back to Dashboard

Claims for Patent: 7,662,365

Title:Polymer conjugates of opioid antagonists
Abstract: The invention provides polymer conjugates of opioid antagonists comprising a polymer, such as poly(ethylene glycol), covalently attached to an opioid antagonist. The linkage between the polymer and the opioid antagonist is preferably hydrolytically stable. The invention also includes a method of treating one or more side effects associated with the use of opioid analgesics, such as constipation, nausea, or pruritus, by administering a polymer conjugate of the invention.
Inventor(s): Bentley; Michael David (Huntsville, AL), Roberts; Michael James (Williamsburg, VA), Shen; Xiaoming (Madison, AL), Cheng; Lin (Huntsville, AL)
Assignee: Nektar Therapeutics (San Carlos, CA)
Application Number:11/332,964
Patent Claims: 1. A polymer conjugate according to the formula: ##STR00009## or pharmaceutically acceptable salt thereof, wherein: Y is allyl; Z is OH; X is amide, amine, carbamate, sulfide, ether, thioether or urea; and POLY is methoxy poly(ethylene glycol), wherein POLY has a molecular weight of from about 100 Da to about 2,000 Da.

2. The polymer conjugate of claim 1, wherein POLY has the formula CH.sub.3O--(CH.sub.2CH.sub.2O).sub.n--CH.sub.2CH.sub.2-- wherein n is from 2 to 45.

3. The polymer conjugate of claim 2, wherein n is from 2 to 20.

4. The polymer conjugate of claim 1, wherein POLY has a molecular weight of from about 100 Da to about 500 Da.

5. The polymer conjugate of claim 1, wherein X is amide.

6. The polymer conjugate of claim 1, wherein X is amine.

7. The polymer conjugate of claim 1, wherein X is carbamate.

8. The polymer conjugate of claim 1, wherein X is sulfide.

9. The polymer conjugate of claim 1, wherein X is ether.

10. The polymer conjugate of claim 1, wherein X is thioether.

11. The polymer conjugate of claim 1, wherein X is urea.

12. A pharmaceutical composition comprising a polymer conjugate and a pharmaceutically acceptable carrier wherein the polymer conjugate has the formula: ##STR00010## or pharmaceutically acceptable salt thereof, wherein: Y is allyl; Z is OH; X is amide, amine, carbamate, sulfide, ether, thioether or urea; and POLY is methoxy poly(ethylene glycol), wherein POLY has a molecular weight of from about 100 Da to about 2,000 Da.

13. The pharmaceutical composition of claim 12, wherein POLY has the formula CH.sub.3O--(CH.sub.2CH.sub.2O).sub.nCH.sub.2CH.sub.2-- wherein n is from 2 to 45.

14. The pharmaceutical composition of claim 12, wherein n is from 2 to 20.

15. The pharmaceutical composition of claim 12, wherein POLY has a molecular weight of from about 100 Da to about 500 Da.

16. The pharmaceutical composition of claim 12, wherein X is amide.

17. The pharmaceutical composition of claim 12, wherein X is amine.

18. The pharmaceutical composition of claim 12, wherein X is carbamate.

19. The pharmaceutical composition of claim 12, wherein X is sulfide.

20. The pharmaceutical composition of claim 12, wherein X is ether.

21. The pharmaceutical composition of claim 12, wherein X is thioether.

22. The pharmaceutical composition of claim 12, wherein X is urea.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Federal Trade Commission
Harvard Business School
Teva
Julphar
Farmers Insurance
Fuji
Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot